Overview
To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions
Status:
Completed
Completed
Trial end date:
2003-09-01
2003-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To demonstrate the bioequivalence of Azithromycin 600 mg Tablets Under Fed Conditions.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
SandozTreatments:
Azithromycin
Criteria
Inclusion Criteria:- No clinically significant abnormal finding on physical exam, medical history, or
clinical laboratory results on screening
Exclusion Criteria:
- Positive test results for HIV or hepatitis B or C
- Treatment for drug or alcohol dependence
- Female subjects who are pregnant or lactating